Aandeel 300601 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Shenzhen Kangtai Biological Products Co., Ltd.

Aandelen

300601

CNE100002Q33

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 25-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
19,39 CNY -0,62% Intraday-grafiek van Shenzhen Kangtai Biological Products Co., Ltd. -4,95% -28,58%
10/01 Kangtai Biological voorspelt terugkeer naar winst in 2023 MT
2023 Shenzhen Kangtai Biological Products Co, Ltd. Rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Kangtai Biological Forecasts Swing to Profit in 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback announced on October 12, 2022 has closed with 3,581,600 shares, representing 0.32% for CNY 120.97 million.
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shares in Chinese Pharma Companies Decline Amid Drop in Vaccination Rates
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 300601
  4. Nieuws Shenzhen Kangtai Biological Products Co., Ltd.
  5. Andere talen